- Select a blog category
by Amen Sanghera
Recently I read that cancer was discovered in a 1.7 million year old ancient human fossil.1 This discovery sparked my interest to understand some of the more recent developments in cancer research and the importance of early diagnosis in successfully treating cancers. Since the 1970s the survival rates for cancer have doubled, with 50 per cent of people diagnosed with cancer now surviving their disease for ten years or more.2
by Tim Smith, Principal, Deloitte Consulting LLP
This week’s blog by Tim Smith, Deloitte’s national leader for Healthcare Information Technology (HIT) in the US, featured on the US Center for Health Solutions blog, A view from the Center, in March 2018.1 Following the HIMSS18 conference in the March 2018, Tim used the blog to explore the importance, challenges and considerations of virtual care programmes for organisations looking to implement them.
by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP
This week’s blog by Greg Reh, Deloitte’s Global Life Sciences Leader first featured on the US Center for Health Solutions blog, A view from the Center.i In it Greg explores how emerging technologies can improve enrolment in, remove barriers of participation and increase drug adherence in pharma clinical trials.
By Debi Rhodes, COO & Clients & Industries Lead, Life Sciences & Healthcare
As part of last week’s Mental Health Awareness Week, Deloitte ran a number of events to raise the profile of this important issue and the support that is available to people. One of the messages that resonated with me was the importance of talking and sharing personal stories. Having just returned from maternity leave, it felt timely to share my brief experience of one of the mental health issues that temporarily affected me, but is an ongoing challenge for so many people – anxiety.
By Karen Taylor, Director, Centre for Health Solutions
The National Council for Palliative Care and their Dying Matters Coalition partners hold a Dying Matters Awareness Week in May every year to raise the profile of the importance of talking about dying, death and bereavement. This year, the week runs from 14th to the 20th of May, under the banner of ‘What Can You Do... in your community?’ For the past four years, I have written a blog to draw attention to this important subject, as I am a passionate advocate for good end-of-life care for all and know first-hand that failing to talk about the possible death of a loved one can have serious and long-term repercussions.
by Dr. Mark Steedman, Research Manager, Centre for Health Solutions
Our recent report The future awakens: Life sciences and health care predictions 2022, uses evidence from today to predict what the world will look like in the year 2022. One of our predictions, ‘The future of medicine is here and now,’ explores how exponential advances in life-extending and precision therapies will improve patient outcomes. Much of the evidence informing this prediction is derived from advances in areas such as genomics, precision medicine and new cancer treatments, including CAR-T cell therapies. However, advances in other scientific areas, such as tissue engineering, are also gaining traction. This week’s blog explores developments in tissue engineering as a whole and zeros in on an exciting new development in retinal tissue engineering.
How harnessing the technologies of the Fourth Industrial Revolution could radically improve patient care
by Karen Taylor, Director, Centre for Health Solutions
This week I attended the launch of a new report, “Powerful Patients, Paperless Systems: How new technology can renew the NHS”.1 The report, authored by Alan Mak MP, Member of Parliament for Havant, and founder of the All Party-Parliamentary Group (APPG) on the Fourth Industrial Revolution (4IR), was published by the Centre for Policy Studies, and proposes ambitious reforms to the NHS. These include shedding paper, pagers and fax machines to create a fully digital NHS that will help patients take control of their treatment. Much of the content resonates with our own thinking, highlighted in our recent reports, – “Time to care: Securing a future for the hospital workforce in the UK” (February 2018) and “The future awakens: Healthcare and Life Sciences Predictions 2022” (November 2017). This week’s blog therefore shares some of the content from the Powerful Patients Paperless Systems (PPPS) report and discusses how this aligns with our own findings and, more importantly, could help health radically improve patient care.
by Terri Cooper, Global Health Care Sector Leader and Chief Inclusion Officer, Deloitte LLP
Inclusion and equality are important forces impacting health care systems globally. Last month the UK government, following legislation introduced in April 2017, made it mandatory for organisations with 250 or more employees to report annually on their gender pay gap.1 The first annual publications shows that for all NHS trust staff, the mean gender pay gap in hourly pay is 15 per cent and the median is 17.4 per cent. While most NHS trusts have gaps that favour men, a few have pay gaps that favour women.
by Karen Taylor
Earlier this week I presented the key findings from our February 2017 report, Time to care: Securing a future for the hospital workforce in the UK, at a breakfast meeting at Northern Ireland’s NHS Confederation (NICON) conference highlighting the hospital workforce challenges and potential solutions for hospitals in the UK. In discussing our findings with an engaged audience, a particularly emotive issue was highlighted – the challenges facing our older and more experienced members of staff. Our research suggests that introducing more flexible working and addressing some of the hygiene factors identified in our report could help address this problem. I therefore thought I would use this week’s blog to explore this issue in more detail.
by Greg Reh
Blockchain technology is continually touted to revolutionise the operations of every industry it becomes associated with, and for health care and life sciences this no different. This week’s blog, by Greg Reh, Deloitte’s Global Life Sciences and Health Care Leader, discusses the possible use cases blockchain may have in health care. The blog first appeared in on the US Center for Health Solutions website, part of their My Take series.i
by Pratik Avhad
India is one of the leading global producers of low-cost generic medicines due to its high domestic demand and inexpensive manufacturing costs. The country’s pharmaceutical market is the world’s third largest in terms of volume, but the thirteenth largest in value.1 However, counterfeiting is pervasive, with an estimated 20 per cent ($4.3 billion in 2013-14) of India’s drug market comprised of counterfeit drugs.2,3 While counterfeiting is a global issue, it is much more prevalent in low and middle income countries with an estimated 10 to 30 per cent of medicines in these countries being counterfeit, compared to just one per cent of medicines in high-income countries.4